Ultrasound Guided vs Unguided Intra-articular Knee Injections
NCT02092246 is a phase 3 interventional trial sponsored by Mayo Clinic. As of 18 Nov 2026, it was withdrawn. It studies Inflammatory Arthritis and Osteoarthritis. The registry lists an enrollment of 0 participants at 1 site in 1 country. The registry lists a start date of 31 Mar 2014 and a primary completion date of 29 Feb 2016.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02092246 |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional trial |
| Lead sponsor | Mayo Clinic |
| Enrollment | 0 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Inflammatory Arthritis and Osteoarthritis |
| Start | 31 Mar 2014 |
| Primary completion | 29 Feb 2016 |
| Study completion | 29 Feb 2016 |
| Last update posted | 15 Oct 2015 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Matthew Pingree, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Rochester
Rochester
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02092246
Each answer restates registry values shown on this page.
What is NCT02092246?
NCT02092246 is a phase 3 interventional trial sponsored by Mayo Clinic. It studies Inflammatory Arthritis and Osteoarthritis.
Who leads NCT02092246?
The registry names Matthew Pingree, MD (principal investigator, Mayo Clinic) as the overall official.
Where does NCT02092246 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT02092246 end?
The registry lists a primary completion date of 29 Feb 2016 and a study completion date of 29 Feb 2016. The sponsor last updated the record on 15 Oct 2015.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.